Rights and permissions
About this article
Cite this article
BMS advises of serious reactions with perflutren. Inpharma Wkly. 1611, 19 (2007). https://doi.org/10.2165/00128413-200716110-00048
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200716110-00048